Telix Pharmaceuticals Limited Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
Telix Pharmaceuticals Limited: Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership
MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA ("ANMI"), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX, "T...
More From BioPortfolio on "Telix Pharmaceuticals Limited: Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership"